Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 25 Neoplasms 8 Neoplasm Metastasis 8 Colorectal Neoplasms 5 Lymphoma, Non-Hodgkin 4 Leukemia, Hairy Cell 4 Multiple Myeloma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Thyroid Neoplasms 2 Thyroid Cancer, Papillary 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Skin Neoplasms 1 Sarcoma, Clear Cell 1 Relapsed Pediatric Solid Tumor 1 Rare Tumour 1

Interventions

tebentafusp 1 dostarlimab 1 cobimetinib 1 cabozantinib 1 atezolizumab 1 Vemurafenib 1 Specimen Handling 1 Radiation Dose Hypofractionation 1 Diathermy 1 Crizotinib 1 Biopsy 1 ARQ 197 1 AMG 337 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Clear Cell × Vemurafenib × Clear all

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡